跳到正文
原文
Medical Xpress·· 2026-10-20AI 评分29

激素治疗与绝经后女性偏头痛负担加重相关:系统综述与Meta分析

Hormone therapy use associated with greater migraine burden in postmenopausal women

AI 导读

一项纳入5项研究、近24,000名绝经后女性的系统综述与Meta分析显示,激素治疗与偏头痛发作更频繁、持续时间更长相关。该分析在2026年The Menopause Society年会上公布,汇总偏头痛发生率为18.94%,但每月镇痛药使用数量和严重程度评分无显著差异。研究者指出仍需临床试验明确机制并指导个体化

正文
older woman unwell
Credit: Unsplash/CC0 Public Domain

Migraines are estimated to affect 10% to 29% of women during the menopause transition, when migraines often worsen and become more frequent, especially during perimenopause. This is due to unpredictable estrogen drops. A new study suggests postmenopausal women using hormone therapy will experience more frequent, longer-lasting migraines. Results of the study were presented at the 2026 Annual Meeting of The Menopause Society in San Diego Oct. 20–24, 2026.

Hormone therapy has proven to be successful in managing a wide array of bothersome menopause symptoms, especially hot flashes. A challenge, however, is that fluctuations in estrogen levels may influence migraines.

Researchers in a new study sought to evaluate the associations of hormone therapy with migraine outcomes, including incidence, severity, frequency, duration and analgesic use in postmenopausal women, independently of the route of administration. They based their findings on five studies that collectively included nearly 24,000 women. The pooled analysis showed a mean migraine incidence of 18.94%.

Based on their findings, the researchers concluded that hormone therapy was associated with increased frequency of migraine attacks and longer duration of migraine episodes. However, no significant differences were observed in the number of analgesics used per month or in migraine severity scores.

Further clinical trials are necessary to better understand the physiopathology and to guide more efficient treatments.

"Migraines can have a significant impact on quality of life, particularly during the menopause transition when many women experience changes in their symptoms. More research is needed to better understand the relationship between hormone therapy and migraine and to help guide individualized treatment decisions," says Dr. Flavia Fairbanks Ruano, lead author from the University of Miami Miller School of Medicine.

Details of the study will be discussed as part of the presentation titled "Impact of Hormone Replacement Therapy on Migraine Outcomes in Postmenopausal Women: A Systematic Review and Meta-Analysis."

"Hormone therapy remains the most effective treatment for bothersome vasomotor symptoms and can be used safely in many women with migraine," says Dr. Stephanie Faubion, medical director for The Menopause Society.

"Because women with migraine may be more likely to seek treatment for menopause symptoms, the findings of this study may reflect underlying differences between women who use hormone therapy and those who do not. More research is needed before drawing conclusions about the effect of hormone therapy on migraine burden."

More information

Impact of Hormone Replacement Therapy on Migraine Outcomes in Postmenopausal Women: A Systematic Review and Meta-Analysis

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Hormone therapy use associated with greater migraine burden in postmenopausal women (2026, October 20) retrieved 20 October 2026 from https://medicalxpress.com/news/2026-10-hormone-therapy-greater-migraine-burden.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com